Alzheimer’s Drug Granted FDA Breakthrough Designation as Space Heats Up
BioSpace
OCTOBER 10, 2021
?The decision is based on promising results from the Marguerite RoAD and SCarlet RoAD open-label extension trials, showing a significant reduction in brain amyloid plaque in Alzheimer's patients.
Let's personalize your content